Newbridge Financial Services Group, Inc. Sorrento Therapeutics, Inc. Transaction History

Newbridge Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$2.0 - $4.9 $1,500 - $3,675	-750 Reduced 10.14%	6,650 $15,000
Q4 2021 Jan 19, 2022	SELL	$4.65 - $7.23 $60,101 - $93,447	-12,925 Reduced 63.59%	7,400 $34,000
Q3 2021 Oct 27, 2021	BUY	$7.41 - $10.99 $16,857 - $25,002	2,275 Added 12.6%	20,325 $155,000
Q2 2021 Sep 07, 2021	BUY	$6.35 - $10.0 $6,350 - $10,000	1,000 Added 5.87%	18,050 $175,000
Q1 2021 Sep 07, 2021	SELL	$7.03 - $16.51 $38,665 - $90,805	-5,500 Reduced 24.39%	17,050 $141,000
Q4 2020 Sep 07, 2021	SELL	$5.76 - $11.95 $25,056 - $51,982	-4,350 Reduced 16.17%	22,550 $154,000
Q3 2020 Sep 07, 2021	BUY	$6.17 - $18.82 $165,973 - $506,258	26,900 New	26,900 $300,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.